Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1960 1
1985 1
1986 1
1987 1
1988 2
1989 5
1990 7
1991 9
1992 7
1993 7
1994 5
1995 2
1996 6
1997 5
1998 7
1999 3
2000 2
2001 2
2002 2
2003 2
2004 3
2005 3
2007 1
2008 1
2009 2
2010 2
2011 5
2012 3
2013 4
2014 6
2015 2
2016 5
2017 4
2018 2
2019 5
2020 4
2021 4
2022 9
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium.
Rivera-Lebron B, McDaniel M, Ahrar K, Alrifai A, Dudzinski DM, Fanola C, Blais D, Janicke D, Melamed R, Mohrien K, Rozycki E, Ross CB, Klein AJ, Rali P, Teman NR, Yarboro L, Ichinose E, Sharma AM, Bartos JA, Elder M, Keeling B, Palevsky H, Naydenov S, Sen P, Amoroso N, Rodriguez-Lopez JM, Davis GA, Rosovsky R, Rosenfield K, Kabrhel C, Horowitz J, Giri JS, Tapson V, Channick R; PERT Consortium. Rivera-Lebron B, et al. Among authors: palevsky h. Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619853037. doi: 10.1177/1076029619853037. Clin Appl Thromb Hemost. 2019. PMID: 31185730 Free PMC article.
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Spikes LA, Bajwa AA, Burger CD, Desai SV, Eggert MS, El-Kersh KA, Fisher MR, Johri S, Joly JM, Mehta J, Palevsky HI, Ramani GV, Restrepo-Jaramillo R, Sahay S, Shah TG, Deng C, Miceli M, Smith P, Shapiro SM. Spikes LA, et al. Among authors: palevsky hi. Pulm Circ. 2022 Apr 7;12(2):e12063. doi: 10.1002/pul2.12063. eCollection 2022 Apr. Pulm Circ. 2022. PMID: 35514770 Free PMC article.
Heterogeneity of treatment effects by risk in pulmonary arterial hypertension.
Pan HM, McClelland RL, Moutchia J, Appleby DH, Fritz JS, Holmes JH, Minhas J, Palevsky HI, Urbanowicz RJ, Kawut SM, Al-Naamani N. Pan HM, et al. Among authors: palevsky hi. Eur Respir J. 2023 Jul 27;62(1):2300190. doi: 10.1183/13993003.00190-2023. Print 2023 Jul. Eur Respir J. 2023. PMID: 37169384
Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
Weatherald J, Moutchia J, Al-Naamani N, McClelland RL, Ventetuolo CE, Palevsky HI, Harhay MO, Kawut SM. Weatherald J, et al. Among authors: palevsky hi. Am J Respir Crit Care Med. 2023 Dec 1;208(11):1231-1234. doi: 10.1164/rccm.202305-0800LE. Am J Respir Crit Care Med. 2023. PMID: 37734029 No abstract available.
Systemic arterial properties in pulmonary hypertension.
Goodman R, Chirinos JA, Ky B, Mazurek JA, Smith KA, Palevsky HI, Fritz JS, Pugliese SC, Kawut SM, Al-Naamani N. Goodman R, et al. Among authors: palevsky hi. Pulm Circ. 2021 Nov 14;11(4):20458940211055684. doi: 10.1177/20458940211055684. eCollection 2021 Oct-Dec. Pulm Circ. 2021. PMID: 34804490 Free PMC article. No abstract available.
141 results